dc.contributor.author |
Zaldivar Villon, M.L.F. |
|
dc.contributor.author |
de la Rocha, J.A.L. |
|
dc.contributor.author |
Espinoza, L.R. |
|
dc.date.accessioned |
2019-08-08T15:23:45Z |
|
dc.date.available |
2019-08-08T15:23:45Z |
|
dc.date.issued |
2019 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/7136 |
|
dc.description.abstract |
Purpose of Review: Takayasu arteritis (TA) is a granulomatous inflammatory disorder that affects large vessels, especially aorta and its proximal branches. Its diagnosis can be extremely challenging due to the non-specificity of the systemic inflammatory manifestations during the early phase of the disease and usually follows an insidious clinical course until the emergence of vascular ischemic complications. Recent Findings: Its pathogenesis has been better delineated in recent years, especially the role of HLA-B*52 allele in certain ethnic groups, as well as the use of biological therapy, and surgical revascularization. Recent findings are discussed in depth. Summary: Clinical and epidemiological aspects of TA, recent developments in pathogenesis, and therapy are presented. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer |
|
dc.relation.ispartofseries |
Current Rheumatology Reports |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
epidemiology |
en_US |
dc.subject |
human |
en_US |
dc.subject |
ethnicity |
en_US |
dc.subject |
Review |
en_US |
dc.subject |
heart muscle revascularization |
en_US |
dc.subject |
Aortitis |
en_US |
dc.subject |
fluorodeoxyglucose f 18 |
en_US |
dc.subject |
positron emission tomography |
en_US |
dc.subject |
allele |
en_US |
dc.subject |
tumor necrosis factor |
en_US |
dc.subject |
biological therapy |
en_US |
dc.subject |
clinical feature |
en_US |
dc.subject |
nuclear magnetic resonance imaging |
en_US |
dc.subject |
pathogenesis |
en_US |
dc.subject |
disease activity |
en_US |
dc.subject |
glucocorticoid |
en_US |
dc.subject |
computer assisted tomography |
en_US |
dc.subject |
disease classification |
en_US |
dc.subject |
cyclophosphamide |
en_US |
dc.subject |
methotrexate |
en_US |
dc.subject |
echography |
en_US |
dc.subject |
interleukin 17 |
en_US |
dc.subject |
interleukin 6 |
en_US |
dc.subject |
interleukin 8 |
en_US |
dc.subject |
laboratory test |
en_US |
dc.subject |
interleukin 9 |
en_US |
dc.subject |
abatacept |
en_US |
dc.subject |
azathioprine |
en_US |
dc.subject |
leflunomide |
en_US |
dc.subject |
rituximab |
en_US |
dc.subject |
mycophenolate mofetil |
en_US |
dc.subject |
angiography |
en_US |
dc.subject |
aortic arch syndrome |
en_US |
dc.subject |
artery lesion |
en_US |
dc.subject |
Biologic therapy |
en_US |
dc.subject |
cardiac imaging |
en_US |
dc.subject |
CD19 antigen |
en_US |
dc.subject |
CD20 antigen |
en_US |
dc.subject |
CD27 antigen |
en_US |
dc.subject |
Granulomatous disease |
en_US |
dc.subject |
HLA B52 antigen |
en_US |
dc.subject |
Imaging studies |
en_US |
dc.subject |
interleukin 18 |
en_US |
dc.subject |
magnetic resonance angiography |
en_US |
dc.subject |
Surgical revascularization |
en_US |
dc.subject |
tocilizumab |
en_US |
dc.subject |
Vasculitis |
en_US |
dc.title |
Takayasu Arteritis: Recent Developments |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1007/s11926-019-0848-3 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.17 |
|
dc.relation.issn |
1534-6307 |
|